Lilly has demonstrated their ability to bring complex peptide therapies through the regulatory process, and their phase 3 TRIUMPH trial program for retatrutide includes multiple studies across different patient populations
A recent review Trusted Source PubMed Central Go to source looked at the impact of obesity on IBD
ADVANCED MATERIALS FOR A LOWER FOOTPRINT While new delivery solutions are being explored, many of todays GLP-1 therapies still rely on established autoinjector platforms
Cochrane Database Syst Rev (Systematic review) (2): CD003158
Maximizing GLP-1 Therapy Beyond Weight Loss The benefits of GLP-1 therapy are extensive, which include improved glucose, reduced cardiovascular disease risk, and enhancements in inflammation, sleep apnea, and even addiction or impulse control
Real Results What happens when you commit to the protocol